484
Views
4
CrossRef citations to date
0
Altmetric
Author's View

Monoclonal antibody targeting of mononuclear cell chemokines driving malignant pleural effusion

&
Article: e29195 | Received 08 May 2014, Accepted 09 May 2014, Published online: 11 Jun 2014

References

  • Ryu JS, Ryu HJ, Lee SN, Memon A, Lee SK, Nam HS, Kim HJ, Lee KH, Cho JH, Hwang SS. Prognostic impact of minimal pleural effusion in non-small-cell lung cancer. J Clin Oncol 2014; 32:960 - 7; http://dx.doi.org/10.1200/JCO.2013.50.5453; PMID: 24550423
  • Postmus PE, Brambilla E, Chansky K, Crowley J, Goldstraw P, Patz EF Jr., Yokomise H, International Association for the Study of Lung Cancer International Staging Committee, Cancer Research and Biostatistics, Observers to the Committee, Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer. J Thorac Oncol 2007; 2:686 - 93; http://dx.doi.org/10.1097/JTO.0b013e31811f4703; PMID: 17762334
  • Maskell NA. Treatment options for malignant pleural effusions: patient preference does matter. JAMA 2012; 307:2432 - 3; http://dx.doi.org/10.1001/jama.2012.5543; PMID: 22609878
  • Marazioti A, Blackwell TS, Stathopoulos GT. The lymphatic system in malignant pleural effusion. Drain or immune switch?. Am J Respir Crit Care Med 2014; 189:626 - 7; http://dx.doi.org/10.1164/rccm.201401-0140ED; PMID: 24628311
  • Stathopoulos GT, Kalomenidis I. Malignant pleural effusion: tumor-host interactions unleashed. Am J Respir Crit Care Med 2012; 186:487 - 92; http://dx.doi.org/10.1164/rccm.201203-0465PP; PMID: 22652027
  • Stathopoulos GT, Kollintza A, Moschos C, Psallidas I, Sherrill TP, Pitsinos EN, Vassiliou S, Karatza M, Papiris SA, Graf D, et al. Tumor necrosis factor-alpha promotes malignant pleural effusion. Cancer Res 2007; 67:9825 - 34; http://dx.doi.org/10.1158/0008-5472.CAN-07-1064; PMID: 17942913
  • Stathopoulos GT, Sherrill TP, Karabela SP, Goleniewska K, Kalomenidis I, Roussos C, Fingleton B, Yull FE, Peebles RS Jr., Blackwell TS. Host-derived interleukin-5 promotes adenocarcinoma-induced malignant pleural effusion. Am J Respir Crit Care Med 2010; 182:1273 - 81; http://dx.doi.org/10.1164/rccm.201001-0001OC; PMID: 20595227
  • Stathopoulos GT, Zhu Z, Everhart MB, Kalomenidis I, Lawson WE, Bilaceroglu S, Peterson TE, Mitchell D, Yull FE, Light RW, et al. Nuclear factor-kappaB affects tumor progression in a mouse model of malignant pleural effusion. Am J Respir Cell Mol Biol 2006; 34:142 - 50; http://dx.doi.org/10.1165/rcmb.2005-0130OC; PMID: 16210694
  • Stathopoulos GT, Psallidas I, Moustaki A, Moschos C, Kollintza A, Karabela S, Porfyridis I, Vassiliou S, Karatza M, Zhou Z, et al. A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion. J Natl Cancer Inst 2008; 100:1464 - 76; http://dx.doi.org/10.1093/jnci/djn325; PMID: 18840818
  • Marazioti A, Kairi CA, Spella M, Giannou AD, Magkouta S, Giopanou I, Papaleonidopoulos V, Kalomenidis I, Snyder LA, Kardamakis D, et al. Beneficial impact of CCL2 and CCL12 neutralization on experimental malignant pleural effusion. PLoS One 2013; 8:e71207; http://dx.doi.org/10.1371/journal.pone.0071207; PMID: 23967166

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.